Mark A. Lemmon

For other people called Mark Lemmon, see Mark Lemmon (disambiguation).

Mark Lemmon
FRS
Lemmon in 2016
Born1964 (age 59–60)
Norfolk, England
EducationNorwich School
Alma mater
Scientific career
Fields
Institutions
ThesisSpecific interactions between transmembrane alpha-helices: Their role in the oligomerisation of integral membrane proteins (1993)
Doctoral advisorDonald Engelman
Website

Mark Andrew Lemmon FRS[2] (born 1964) an English-born biochemist, is the Alfred Gilman Professor and Department Chair of Pharmacology at Yale University where he also directs the Cancer Biology Institute.[1][3][4]

  1. ^ a b c Mark A. Lemmon publications indexed by Google Scholar Edit this at Wikidata
  2. ^ Cite error: The named reference frs was invoked but never defined (see the help page).
  3. ^ Mark A. Lemmon publications indexed by the Scopus bibliographic database. (subscription required)
  4. ^ "Mark Andrew Lemmon, PhD: Professor of Pharmacology; Director, Cancer Biology Institute". yale.edu. Yale University. Archived from the original on 21 April 2016.